ClinOne CEO Rob Bohacs to Speak at Rocky Mountain Life Science Investor and Partnering Conference
DENVER, August 22, 2019 – ClinOne has announced that its CEO, Rob Bohacs, will speak at the Rocky Mountain Life Science Investor and Partnering Conference on September 5th in Vail, CO. This 2 day conference brings together life science innovators and investors alike from around the nation. Mr. Bohacs will be speaking about ClinOne’s experience as a leader in the clinical trials technology space, and their rapid growth. Having been named one of the “Top 19 Companies to Watch in 2019” by Colorado Inno, ClinOne was also included in the “Top 10 eClinical Companies” List by Pharmatech Outlook Magazine earlier this year. “We are incredibly proud of how we contribute to and have an impact on clinical trials,” states Bohacs. As an industry leader, ClinOne has much to share on how they are changing the landscape of clinical trials and how they are run, both here and abroad.
The Rocky Mountain Life Science Investor & Partnering Conference takes place in Vail, Colorado September 4-5, 2019. It aims to bring together leading investors and strategic partners from across the U.S. and the region’s top life science companies to cultivate partnerships and source investment opportunities in the areas of medical device, diagnostic, biotech, pharma and digital health. Other speakers include: Garrett Vygantas, MD of OSF Ventures, Emmanuel Fombu, MD, MBA of Johnson & Johnson and Kimberly Muller, CU Healthcare Innovation Fund.
ClinOne offers a complete suite of mobile and web applications to enhance patient, family, caregiver and site engagement. Currently, our solutions help support nearly 3,000 clinical studies across 1,900 research sites in 55 countries across 35 languages. To learn more or to schedule a demo, please contact us. Visit www.clinone.com for more information or email email@example.com.